IbisVision Limited specializes in developing a visual field test software application aimed at the early detection of glaucoma, a leading cause of blindness worldwide. The company's primary product, Ring of Sight (ROS), is a cloud-based solution that enables healthcare professionals to conduct eye tests efficiently. Utilizing patented technology, ROS integrates various eye tests into a single device, offering both Full Threshold and Suprathreshold tests. It is designed for remote and in-practice use, allowing optometrists to deliver high-quality eye care while optimizing their investment. The application operates within a Windows environment and ensures that all patient data is securely stored on encrypted servers to uphold privacy and security. Founded in 2013 and headquartered in Livingston, United Kingdom, IbisVision is committed to advancing eye care through innovative technology.
FluoretiQ Limited is a medical device company based in Bristol, United Kingdom, that focuses on developing advanced technologies for the rapid identification of harmful bacteria. Founded in 2017, the company has created a diagnostic platform known as NANOPLEX, which utilizes proprietary nanomaterials and optical sensing technologies to detect bacterial pathogens in under 15 minutes. This innovative approach combines receptor-mediated sensing with quantum-enhanced optics, facilitating early diagnosis and enabling healthcare professionals to prescribe effective antibiotic treatments more efficiently. FluoretiQ's user-friendly products support accurate same-day diagnoses, ultimately improving patient outcomes by ensuring timely and appropriate antibiotic selection.
Aegiq Ltd. specializes in the development of semiconductor-based quantum photonic chips, utilizing III-V materials such as Gallium, Indium, and Arsenic. Founded in 2019 and headquartered in Sheffield, United Kingdom, the company focuses on creating technology that supports various applications, including broadband quantum communication, imaging, and scalable quantum computing. Aegiq's innovative platform employs a hybrid integrated photonics approach, facilitating economies of scale for quantum technology while enabling multi-million qubit operations. This positions Aegiq to offer a comprehensive range of products and systems in quantum cybersecurity, networking, and computing, significantly enhancing reliability and security compared to traditional silicon-based solutions.
Stent Tek Ltd. is a London-based company founded in 2014 that specializes in developing a catheter-based system for patients undergoing haemodialysis due to kidney failure. The company focuses on providing minimally invasive vascular access solutions through the use of a synthetic connector tube, also known as a covered stent. This innovative approach aims to improve the quality of care for dialysis patients by facilitating easier and safer access to blood vessels. Stent Tek Ltd. operates within a significant market, addressing the needs of a growing population requiring dialysis treatment.
Glucose Republic is a developer of biology-influenced software intended to offer tools to ensure eat and live better by knowing their metabolic intake. They offer a personalized intelligence system, enabling users to measure and predict metabolic responses to the food they eat and the exercise they take.
Glyconics Ltd. is a diagnostics company based in Cambridge, United Kingdom, that develops portable infrared spectroscopy devices for the diagnosis and monitoring of chronic and acute diseases, particularly respiratory conditions such as chronic obstructive pulmonary disease (COPD). Incorporated in 2013, the company has created a hand-held, miniaturized device that enables patients to collect and analyze sputum samples at home. Utilizing Fourier transform infrared spectroscopy (FTIR), the device identifies specific biomarkers associated with COPD, facilitating timely medical assessments and improved patient management.
Smallspark is a Welsh aerospace company with its headquarters in Cardiff Bay, that is working to develop hybrid engine launch vehicle technology to drive the price of access to space to be low enough for anyone to send payloads into space – be it on a sounding rocket or an orbital launch vehicle.
HeadBox Solutions Ltd. operates an online marketplace in the United Kingdom that connects corporate and SME bookers with owners of creative and inspiring off-site meeting spaces. Founded in 2015 and based in Reading, the platform allows guests to efficiently search, book, and pay for various venues suited for a range of events, including workshops, meetings, product launches, and private dining. By facilitating direct bookings, HeadBox enables hosts to monetize under-utilized spaces while providing a seamless experience for users looking to organize events. The service aims to simplify event planning, saving clients time and effort in securing appropriate venues for their needs.
Viscgo Limited designs, develops, and delivers devices and technology to improve the management of dysphagia for patients, caretakers, and clinicians. The company’s product includes drink thickness testers. The company was founded in 2015 and is based in Warrington, United Kingdom.
Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.
VoxSmart Limited is a telecommunications software provider based in London, UK, with additional offices in Madrid, Singapore, and New York. Established in 2006, the company specializes in communications surveillance solutions tailored for the financial services sector. Its flagship product, VSMART, captures, records, stores, transcribes, and analyzes mobile communications, including calls, messages, and voicemails, across various mobile networks and devices. VoxSmart’s solutions enable organizations to effectively manage business risks and ensure compliance with regulatory requirements by providing critical insights and business intelligence in near real-time. The company's offerings include the multi-award winning VoxSmart Mobile Capture, which integrates all communication sources—from phone calls to messaging apps—into a single monitoring platform. This cloud-based solution is designed to operate without disrupting user experience and adheres to global regulations. Recent mergers and acquisitions have enhanced VoxSmart's capabilities in voice and electronic communications surveillance, allowing firms to monitor employee conduct and trading activities efficiently.
LogChain is a logistics platform for the chemical sector. LogChain delivers manufacturers and operators savings, opportunities and full transparency of their trade lanes in real time.
Smallspark is a Welsh aerospace company with its headquarters in Cardiff Bay, that is working to develop hybrid engine launch vehicle technology to drive the price of access to space to be low enough for anyone to send payloads into space – be it on a sounding rocket or an orbital launch vehicle.
Liverpool ChiroChem Limited specializes in the production of chiral small molecules that support research and development in the biotech and pharmaceutical sectors. Established in 2014 and headquartered in Liverpool, UK, with an additional site in Taizhou, China, the company offers a range of products and services, including 3D heterocyclic and carbocyclic APIs and intermediates, custom synthesis, and fragment libraries. Their specialized chemical technologies allow for efficient access to novel chiral building blocks, which are crucial for hit identification and optimization in drug discovery. Liverpool ChiroChem's focus includes the development of chiral piperidines and other sp3-rich nitrogen heterocycles, known for their favorable pharmacokinetic properties. Through years of research in asymmetric hydrogenation and Pd-coupling, the company provides collaborative services to optimize synthetic routes, ensuring a steady supply of innovative drug molecules for the pharmaceutical industry.
Blossom Genetics produces proprietary medicinal cannabis genetics and products. Our mission is to advance medicinal cannabis through scientific research to develop best in class products for our customers.
Elasmogen Ltd, a biopharmaceutical company, discovers and develops sight-saving therapies for inflammatory eye diseases. The company develops soloMER that are small (11 kDa) and stable proteins that have squeezed a fourth binding loop into their single domain format and are derived evolutionarily from a non-antibody lineage, placing them outside the complex/competitive antibody patent landscape. Its pipeline includes ELN/21 and ELN/22, which are auto-immune mediated anti-inflammatory programs; soloMER-drug-conjugates; and NDure, a soloMER (humanized clinical candidate) available for extending the plasma half-life of fused partner molecules, such as scFv, peptides, growth factors, single domains, etc. Elasmogen Ltd has strategic partnerships with Almac Discovery Ltd and Merck Inc. The company was founded in 2014 and is based in Aberdeen, United Kingdom.
Ostara Biomedical Ltd. operates as a biotechnology company that specializes in the development of technologies for artificial reproduction across various mammalian species. The company develops a novel vaginal pessary system to administer female mice for inducing pseudopregnancy prior to embryo transfers. It serves customers in the United Kingdom and internationally. The company was incorporated in 2012 and is based in Liverpool, United Kingdom.
Thalia Design Automation Ltd. is a semiconductor electronic design automation (EDA) company based in Bath, United Kingdom, with an engineering center in Hyderabad, India. Established in 2011, the company specializes in software solutions for the design of analog and mixed-signal integrated circuits. Thalia offers AMALIA, an analog circuit optimizer toolset that employs advanced methodologies and algorithms for circuit solutions, and EMERA, a toolset focused on the design and optimization of power devices using finite element decomposition. Additionally, Thalia provides analog circuit porting services and offers its solutions as Software as a Service (SaaS), allowing customers to access the tools either onsite or via the cloud. The company also engages in custom power device development as an intellectual property service, facilitating the reuse and optimization of existing designs for new technologies and applications.
Automated Smart spine massage machine
Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.
Touch Biometrix Ltd is a company based in Conwy, United Kingdom, founded in 2017, that specializes in the design and development of advanced fingerprint authentication sensors for the consumer electronics sector. The company has created a unique sensing and algorithm platform that allows for the integration of fingerprint sensors in various shapes and sizes, facilitating their use in a wide range of electronic devices. By leveraging innovative sensing technology and a new manufacturing model, Touch Biometrix aims to deliver high-performance fingerprint sensors at competitive prices. The company's goal is to enhance user experience by providing seamless and secure identity authentication, thereby eliminating the reliance on traditional password systems.
As featured on the BBC, TimeOut London, Evening Standard, and Conde Nast Traveler. TubeChat is the only free to download iPhone group messaging app that works on the London Underground where there is no cellular or wifi. TubeChat uses Bluetooth on your iPhone to make automatic incognito connections to people with the same app up to 200 meters away allowing you to chat and play underground. What can you do on TubeChat? LINK - UP: Make new friends. TubeChat facilitates real-life conversations and meetings in areas where other popular social networking or dating apps just don’t work. CHAT: Group chat safely completely ad-free with up to 10 other users nearby. We don’t reveal your identity unless you want to. Maintain your mystery by not updating your profile picture. PLAY: With TubeChat you will be able to play classic games such as I Spy. Have you got a favourite game you’d like to see in the app? Let us know and we’ll see what we can do.
Compono, operating under Shortlyster Pty Ltd, specializes in developing a hiring optimization platform designed to streamline the recruitment process for employers. Founded in 2016 and based in Sydney, Australia, the company provides an online platform that facilitates job listings, defines organizational fit criteria, and manages applications for open positions. This platform allows employers to assess candidates' compatibility with the organization, prioritize selection criteria, replicate job postings, and recalculate candidate scores based on their skills and qualifications. Additionally, Compono offers access to a talent database, enhancing businesses' capacity to make informed, employee-centric decisions throughout the entire employee lifecycle.
Keia is an online platform that connects wellness service practitioners with consumers, offering a wide range of services including acupuncture, massage, physiotherapy, relationship counseling, and yoga. With coverage spanning 27 areas and continually expanding, Keia aims to make wellness services accessible and affordable for everyone. The company provides healthcare professionals with a comprehensive suite of cloud-based business management software, enabling them to efficiently manage and grow their practices. By leveraging technology, Keia facilitates easier access to wellness therapies and helps patients find qualified practitioners in their local communities.
An online comparison tool of robo- and passive advice providers which allows users to input preferred investment objectives and needs to filter these providers to those meeting the input criteria. Jammtoday provides links to the provider’s website allowing users to complete their investment journey directly with their chosen provider.
Mynurva is an online therapy platform based in the UK that focuses on transforming behavioral health services through technology. By offering counseling sessions via live video chats with expert therapists, Mynurva aims to make high-quality and reliable mental health services accessible to everyone. The platform is designed to ensure that users can receive care discreetly and securely, providing a convenient option for individuals seeking support for their mental well-being.
Chainvine Ltd specializes in developing custom platforms and solutions for identity, asset, and encryption management using blockchain technology. The company's distributed ledger technology decentralizes data across a network of nodes, ensuring that transactional data is securely stored in the cloud. Key offerings include Intelligent Commodities, which, when combined with Internet of Things (IoT) partnerships, allows businesses to track physical commodities and gather supply chain data. Additionally, Chainvine provides Intelligent Contracts, facilitating the management of digital contracts and ensuring that all operational changes are recorded. Founded in 2015 and headquartered in Ipswich, United Kingdom, Chainvine focuses on enhancing accountability and operational efficiency for enterprises across finance, supply chain, and IoT sectors.
Touch Biometrix Ltd is a company based in Conwy, United Kingdom, founded in 2017, that specializes in the design and development of advanced fingerprint authentication sensors for the consumer electronics sector. The company has created a unique sensing and algorithm platform that allows for the integration of fingerprint sensors in various shapes and sizes, facilitating their use in a wide range of electronic devices. By leveraging innovative sensing technology and a new manufacturing model, Touch Biometrix aims to deliver high-performance fingerprint sensors at competitive prices. The company's goal is to enhance user experience by providing seamless and secure identity authentication, thereby eliminating the reliance on traditional password systems.
vTime Limited is a Liverpool-based company that specializes in augmented reality and virtual reality software development. Founded in 2013, the company offers a cloud-based engagement platform designed for both consumer and commercial use. Its flagship product, the vTime app, facilitates communication and social interaction among users in virtual environments, allowing them to connect through various digital devices. The app is accessible on multiple platforms, including Gear virtual reality, Cardboard, Oculus Rift, and Daydream, and has been available for free since December 2015. With its innovative approach to virtual engagement, vTime Limited has successfully connected hundreds of thousands of users worldwide and is recognized as a prominent player in the European technology sector.
Liverpool ChiroChem Limited specializes in the production of chiral small molecules that support research and development in the biotech and pharmaceutical sectors. Established in 2014 and headquartered in Liverpool, UK, with an additional site in Taizhou, China, the company offers a range of products and services, including 3D heterocyclic and carbocyclic APIs and intermediates, custom synthesis, and fragment libraries. Their specialized chemical technologies allow for efficient access to novel chiral building blocks, which are crucial for hit identification and optimization in drug discovery. Liverpool ChiroChem's focus includes the development of chiral piperidines and other sp3-rich nitrogen heterocycles, known for their favorable pharmacokinetic properties. Through years of research in asymmetric hydrogenation and Pd-coupling, the company provides collaborative services to optimize synthetic routes, ensuring a steady supply of innovative drug molecules for the pharmaceutical industry.
Renephra Ltd is a medical device company developing a groundbreaking Transdermal Fluid Removal (TFR) technology for minimally invasive fluid removal.
We are targeting the significant problems of fluid overload and chronic oedema / lymphoedema in vascular, oncology and other disease areas.
This is a substantial patient group with unmet clinical needs and is an estimated £1billion market worldwide.
Having achieved proof of concept in humans, Renephra is raising £400k to conduct device development study and design feasability.
Zilico Limited is a Manchester-based company focused on developing diagnostic devices aimed at improving cancer detection, particularly cervical cancer. Utilizing electrical impedance spectroscopy technology, Zilico's flagship product, ZedScan, operates alongside colposcopy to provide real-time, objective assessments of cervical epithelial tissue. This technology addresses the limitations of traditional diagnostic methods, which often involve subjective interpretations. Zilico is actively working on two applications: one targeting the referral market and another aimed at the screening market, both designed to enhance diagnostic accuracy and reduce the subjectivity associated with current practices. Since its founding in 2006, Zilico has aimed to deliver significant health economic benefits and improve cancer screening programs. The company was previously known as Aperio Diagnostics Limited before rebranding in 2008.
Keia is an online platform that connects wellness service practitioners with consumers, offering a wide range of services including acupuncture, massage, physiotherapy, relationship counseling, and yoga. With coverage spanning 27 areas and continually expanding, Keia aims to make wellness services accessible and affordable for everyone. The company provides healthcare professionals with a comprehensive suite of cloud-based business management software, enabling them to efficiently manage and grow their practices. By leveraging technology, Keia facilitates easier access to wellness therapies and helps patients find qualified practitioners in their local communities.
Cell Lane Ltd
Seed Round in 2017
Cell Lane Ltd has been established to develop a cell isolation and separation platform technology, based on intellectual property assigned from the University of Leeds. This new technology seeks to assist in the future treatment of chronic diseases such as cancer and AIDS, and is intended to enable new fields of research in research activities such stem cell research. The Company’s proposed technology can be used to rapidly separate cells whilst preserving their functionality and overall viability. Cell Lane is in the process of developing its technology to a point where it has a Minimum Viable Product (‘MVP’), the MVP (i.e. the new platform) will then be developed and taken forwards to be commercialised by the Company.
Hurricane Modular Commerce Limited, founded in 2016 and based in Saint Albans, United Kingdom, specializes in providing a fully compliant landed cost engine. The company leverages over 100 years of combined experience in logistics, transport, and information technology to offer tailored solutions for businesses. Hurricane Modular Commerce focuses on delivering a flexible pricing structure that enables clients to accurately budget for tax and import duty calculations, ensuring compliance and efficiency in their operations.
Automated Smart spine massage machine
Sky Medical Technology Limited develops innovative neuromuscular electro-stimulation medical devices aimed at enhancing vascular health. Their flagship products include the geko device, which stimulates the common peroneal nerve to activate muscle pumps and improve blood flow, and the firefly device, designed for athletes to enhance lower limb circulation for quicker recovery. The company's OnPulse™ therapy represents a significant advancement in bioelectronic medicine, offering clinically proven solutions for various acute and chronic circulatory conditions, including the prevention of blood clots, treatment of swelling post-surgery, and management of non-healing wounds. These devices are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, across NHS and private hospitals, as well as in clinical studies. Sky Medical Technology distributes its products globally, reaching markets in Asia, Europe, the Middle East, and North America. Founded in 2006 and based in High Wycombe, United Kingdom, the company addresses the needs of over forty million individuals facing vascular-related health challenges.
Stent Tek Ltd. is a London-based company founded in 2014 that specializes in developing a catheter-based system for patients undergoing haemodialysis due to kidney failure. The company focuses on providing minimally invasive vascular access solutions through the use of a synthetic connector tube, also known as a covered stent. This innovative approach aims to improve the quality of care for dialysis patients by facilitating easier and safer access to blood vessels. Stent Tek Ltd. operates within a significant market, addressing the needs of a growing population requiring dialysis treatment.
Metix Limited manufactures patient monitoring devices. The company was founded in 2013 and is based in Glasgow, United Kingdom.
Tookie Limited, founded in 2015 and based in Liverpool, United Kingdom, specializes in the development and sale of innovative online medical vests specifically designed for children undergoing chemotherapy. The Tookie Vest for Oncology secures central venous catheters (CVCs), which are essential for administering long-term medical treatments such as chemotherapy, pain management, and nutrition. Traditional methods of securing these catheters can cause discomfort and anxiety for both patients and their families, as they often result in restricted movement and increased risk of complications like infections. Tookie's vests address these issues by providing a secure and comfortable option that enhances the safety of treatment lines, thereby improving the overall quality of life for young patients and offering peace of mind to their caregivers.
DynamX Medical specializes in the development of a cost-effective and reliable precancer screening system designed for rapid tissue biopsy analysis. This innovative technology enables point-of-care operation, allowing nurses to efficiently conduct screenings in various clinical settings. The company's focus on creating accessible diagnostic tools aims to enhance the identification of healthy and benign tissue specimens, ultimately improving patient care and outcomes. Established in London, United Kingdom, DynamX Medical has positioned itself at the forefront of advancements in medical diagnostics since its inception.
Levitex Foams
Seed Round in 2017
Levitex Foams Ltd was founded to address an identified need in the healthcare market for quality therapeutic mattresses. The company has developed a new Levitex foam product that directly addresses poor body alignment and posture, with a particular focus on those users that are bed-bound. Failure to address poor posture whilst bed-bound can significantly exacerbate a patient’s condition, potentially leading to pressure sores and sleep deprivation resulting in a worsening of the patient’s health condition, leading to an extended and more costly stay in hospital. Levitex has developed a postural management sleep system (class 1 medical device) for those patients suffering with complex neurological illness or Injury, including Multiple Sclerosis, Cerebral Palsy, Motor Neurone Disease, as well as sufferers of stroke and hypoxic brain injury: the company is currently listed as a supplier to the NHS.
Automated Smart spine massage machine
T-EDTA
Venture Round in 2017
T-EDTA Limited was established to develop anti-biofilm technologies and infection control products. Anti-biofilm is used in advanced wound care products using the anti-biofilm agents tri sodium/tetra sodium EDTA (‘t-EDTA’). A biofilm is a group of microorganisms in which cells stick to each other and often adhere to a surface, such as wound. As such, they represent a major risk of woundsite infection. EDTA is a chemical which can inhibit the development of such biofilms. Biofilms are a major problem for human infections and medical device related infections due to their becoming resistant to antibiotics, with the result being wounds that are slow to heal, or not healing/remaining open. The patented tri and tetrasodium EDTA (‘T-EDTA’) can be used to prevent and control infection in three specific areas; advanced wound care, catheters and consumer wellness (Skin/foot fungal infections).
Keia is an online platform that connects wellness service practitioners with consumers, offering a wide range of services including acupuncture, massage, physiotherapy, relationship counseling, and yoga. With coverage spanning 27 areas and continually expanding, Keia aims to make wellness services accessible and affordable for everyone. The company provides healthcare professionals with a comprehensive suite of cloud-based business management software, enabling them to efficiently manage and grow their practices. By leveraging technology, Keia facilitates easier access to wellness therapies and helps patients find qualified practitioners in their local communities.
Nuchido Ltd, founded in 2017 and based in Newcastle upon Tyne, United Kingdom, specializes in the development of cosmeceutical products. These products merge the functionalities of cosmetics and pharmaceuticals, incorporating bioactive ingredients that are supported by scientific validation. Nuchido aims to meet the increasing consumer demand for effective skincare solutions that offer both cosmetic benefits and therapeutic properties. By focusing on the scientific basis of its formulations, the company positions itself at the intersection of beauty and health, catering to a market that seeks innovative and reliable skincare options.
Elasmogen Ltd, a biopharmaceutical company, discovers and develops sight-saving therapies for inflammatory eye diseases. The company develops soloMER that are small (11 kDa) and stable proteins that have squeezed a fourth binding loop into their single domain format and are derived evolutionarily from a non-antibody lineage, placing them outside the complex/competitive antibody patent landscape. Its pipeline includes ELN/21 and ELN/22, which are auto-immune mediated anti-inflammatory programs; soloMER-drug-conjugates; and NDure, a soloMER (humanized clinical candidate) available for extending the plasma half-life of fused partner molecules, such as scFv, peptides, growth factors, single domains, etc. Elasmogen Ltd has strategic partnerships with Almac Discovery Ltd and Merck Inc. The company was founded in 2014 and is based in Aberdeen, United Kingdom.
SurveyMe is an innovative application designed to capture real-time customer feedback through mobile surveys, emphasizing the importance of 'Point of Experience' insights. This platform allows users to provide feedback while earning rewards and coupons, creating a mutually beneficial relationship between businesses and customers. The app is user-friendly and cost-effective, enabling businesses to quickly gather and analyze valuable feedback to drive growth and improve customer satisfaction. SurveyMe continuously compiles this data into clear and actionable management information, which can be accessed almost instantly. Users can download the app for free and register for a basic account to begin utilizing its features.
VoxSmart Limited is a telecommunications software provider based in London, UK, with additional offices in Madrid, Singapore, and New York. Established in 2006, the company specializes in communications surveillance solutions tailored for the financial services sector. Its flagship product, VSMART, captures, records, stores, transcribes, and analyzes mobile communications, including calls, messages, and voicemails, across various mobile networks and devices. VoxSmart’s solutions enable organizations to effectively manage business risks and ensure compliance with regulatory requirements by providing critical insights and business intelligence in near real-time. The company's offerings include the multi-award winning VoxSmart Mobile Capture, which integrates all communication sources—from phone calls to messaging apps—into a single monitoring platform. This cloud-based solution is designed to operate without disrupting user experience and adheres to global regulations. Recent mergers and acquisitions have enhanced VoxSmart's capabilities in voice and electronic communications surveillance, allowing firms to monitor employee conduct and trading activities efficiently.
EligoChem Ltd specializes in the design and development of amphiphilic compound libraries aimed at enhancing drug discovery processes. Founded in 2012 and based in Sandwich, United Kingdom, the company focuses on creating drug-like compounds for screening, along with providing medicinal and computational chemistry support for lead optimization. EligoChem has developed proprietary technology that produces highly water-soluble drugs, which are more readily absorbed by the human body. This innovative approach addresses a significant gap in current pharmaceutical screening collections, as only a small fraction of known drug compounds exhibit both polar and lipophilic properties. Additionally, the company offers consultancy services in medicinal and computational chemistry, with a particular emphasis on safer drug design and antibiotic drug development.
RealSpace is a cloud-based software empowering real estate professionals to effectively manage all aspects of running their business online. Real Space Limited has developed a novel, wide field-of-view multi-purpose synoptic virtual reality viewer called ‘SingleReality’, to exploit what the founders perceive as a gap in the growing VR market for a completely new headset design that offers a best-in-class user experience and is also significantly cheaper than other current available market offerings. The Company’s strategy is to offer a superior VR experience by delivering identical images to each eye from a single 2D, high resolution image. This synoptic approach is a novel addition to the VR Head-Mounted Display device market.
Viscgo Limited designs, develops, and delivers devices and technology to improve the management of dysphagia for patients, caretakers, and clinicians. The company’s product includes drink thickness testers. The company was founded in 2015 and is based in Warrington, United Kingdom.
Parkure Ltd is a drug discovery company focused on researching and developing treatments for Parkinson's disease. Founded in 2014 and based in Edinburgh, United Kingdom, Parkure employs an innovative in-vivo drug discovery platform that utilizes fruit flies for drug screening and repurposing. This approach aims to mitigate risks in the drug development process by testing drugs in living organisms rather than in vitro methods. By concentrating on the degeneration of nerve cells, Parkure seeks to provide the medical industry with effective therapies to combat Parkinson's disease.
Transcriptogen Ltd. specializes in discovering novel transcription factor inhibitors aimed at treating various cancers. The company focuses on inhibiting key transcription factors such as NFκB, STAT3, HIF1, and AP1, which play critical roles in cancer cell growth. Its lead molecule, TSG1301, is a hybrid compound that selectively binds to specific DNA motifs associated with NFκB, demonstrating effectiveness in treating breast and pancreatic cancers with low toxicity. This positions TSG1301 as a potential side-effect-free therapeutic option. Additionally, Transcriptogen has developed a drug discovery platform designed to identify new transcription factor inhibitors for future clinical development, while also providing pharmacogenomics assays to identify patients with dysregulated transcription factor signaling pathways for targeted clinical trials. Founded in 2013, Transcriptogen is headquartered in Bath, United Kingdom.
PeptiGelDesign Ltd. specializes in the development and commercialization of self-assembling peptide-based hydrogels, which are designed to create defined three-dimensional microenvironments for various cell culture applications. The company offers products that are ready-to-use and easy to handle, suitable for culture dishes, multi-well plates, and cell culture inserts. These hydrogels serve as substrates for two-dimensional cell cultures and facilitate the encapsulation of cells for three-dimensional cultures. Additionally, PeptiGelDesign provides cardiovascular medical devices, including a biocompatible and biodegradable cardiac patch aimed at offering mechanical support to damaged heart tissue. Since its incorporation in 2013, the company has been based in Alderley Edge, United Kingdom, and also offers design services to further support the life science industry.
Filisia Interfaces Ltd. specializes in developing multimedia and multisensory devices aimed at enhancing training and rehabilitation for individuals with special education and rehabilitation needs. Founded in 2014 and based in London, the company offers Monoma, a training system designed for people with learning and physical disabilities. Filisia’s solutions leverage creative technology, integrating music and games to engage users in physical, cognitive, and communication skill development. The company's software features gamified rehabilitation exercises tailored to various conditions, with multiple difficulty levels to assess and improve user capabilities. Additionally, it provides valuable data analytics to track progress in physical and cognitive skills, addressing the challenges of traditional rehabilitation methods, which can be costly and monotonous. By focusing on innovative, engaging training solutions, Filisia aims to optimize therapy outcomes and reduce care costs for the estimated 150 million individuals worldwide with special education and rehabilitation needs.
Fen EP Limited is engaged in the development of a biomedical device aimed at preventing sudden cardiac death. The company focuses on invasive cardiac electrophysiology instrumentation, which is based on academic research involving paced electrogram fractionation analysis. This technology enables healthcare professionals to predict the risk of sudden cardiac death and take appropriate preventive measures. Through its innovative approach, Fen EP Limited seeks to enhance patient outcomes in cardiac care.
Elucid mHealth Limited is a medication technology company based in Manchester, United Kingdom, focused on enhancing clinical trial efficiencies through innovative adherence monitoring tools. Incorporated in 2013, the company developed Pill Connect, a sophisticated pill bottle that facilitates real-time remote monitoring of medication adherence. This product allows trial organizers to access vital data on patient dosing, including missed doses, new doses, and overall engagement metrics. By providing a feedback system that connects individual user doses to provider monitoring systems, Elucid mHealth aims to improve the accuracy and efficiency of clinical trials while addressing non-adherence issues.
Aurio Limited has developed a patentable core technology that potentially eases the debilitating effects of tinnitus. Tinnitus is a perception of sound in the absence of an external source. Although it is often referred to as ‘ringing in the ears’, tinnitus can also be perceived as many different sounds including hissing, clicking or whistling. A common condition, it affects approximately 1 in every 10 adults, especially those over the age of 60. Common causes are excessive or cumulative noise exposure, head and neck injuries, and ear infections. In a small number of individuals, tinnitus is a sign of a serious underlying medical condition. The adverse impacts of tinnitus include insomnia, poor concentration and performance, irritability, anxiety and depression.
Pronec Ltd seeks to develop a new class of cancer therapy that causes tumours to simply die, using proprietary peptides. The Company has identified a lead candidate molecule that causes necrosis of a wide range of tumour cell lines in culture, but does not affect normal cell lines. Cancer cell necrosis refers to death of cancer cells within a tumour. This new class of compounds is protected by GB and international patent applications.
Funnel Music is an innovative platform focused on the creation and marketing of new music. It aims to disrupt traditional methods by implementing a shared outcome agreement that facilitates the development of artists over extended periods with reduced financial burdens. The platform serves as an open community for artists and music professionals, allowing them to collaborate on new projects. By providing expert guidance and mentoring, Funnel Music enhances the career prospects of aspiring musicians, enabling them to navigate the complexities of the music industry more effectively.
Glyconics Ltd. is a diagnostics company based in Cambridge, United Kingdom, that develops portable infrared spectroscopy devices for the diagnosis and monitoring of chronic and acute diseases, particularly respiratory conditions such as chronic obstructive pulmonary disease (COPD). Incorporated in 2013, the company has created a hand-held, miniaturized device that enables patients to collect and analyze sputum samples at home. Utilizing Fourier transform infrared spectroscopy (FTIR), the device identifies specific biomarkers associated with COPD, facilitating timely medical assessments and improved patient management.
Sky Medical Technology Limited develops innovative neuromuscular electro-stimulation medical devices aimed at enhancing vascular health. Their flagship products include the geko device, which stimulates the common peroneal nerve to activate muscle pumps and improve blood flow, and the firefly device, designed for athletes to enhance lower limb circulation for quicker recovery. The company's OnPulse™ therapy represents a significant advancement in bioelectronic medicine, offering clinically proven solutions for various acute and chronic circulatory conditions, including the prevention of blood clots, treatment of swelling post-surgery, and management of non-healing wounds. These devices are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, across NHS and private hospitals, as well as in clinical studies. Sky Medical Technology distributes its products globally, reaching markets in Asia, Europe, the Middle East, and North America. Founded in 2006 and based in High Wycombe, United Kingdom, the company addresses the needs of over forty million individuals facing vascular-related health challenges.
Videregen Limited is a regenerative medicine company based in Liverpool, United Kingdom, that specializes in developing organ replacement products to combat the chronic shortage of transplantable organs. Founded in 2011 as a spin-out from the Northwick Park Institute of Medical Research, the company focuses on creating biological scaffolds for organ regeneration, specifically targeting trachea, small bowel, and liver replacements. Videregen employs proprietary technology that utilizes decellularized organ scaffolds seeded with a patient's own stem cells, resulting in tailored, non-immunogenic organ replacements. This innovative tissue purification process preserves the natural three-dimensional structure of the source material while producing acellular biological scaffolds. By addressing critical healthcare challenges, Videregen aims to improve patient quality of life and reduce healthcare costs through the development of the first commercially available organ replacement products.
AlgaeCytes Limited is a biotechnology company that specializes in the production of high-value omega oils and bioactive compounds derived from freshwater algae. Its innovative approach focuses on generating Omega 3 fatty acids, which are essential for various bodily functions, including blood clotting and brain cell membrane formation. Recognized for their numerous health benefits, Omega 3 fatty acids may contribute to heart health and have potential therapeutic effects on conditions such as cancer and autoimmune diseases. By utilizing algae, AlgaeCytes aims to reduce the reliance on dwindling fish stocks for omega-rich supplements, thereby catering to vegan consumers and promoting the availability of enhanced, organic health products in the healthcare, personal care, and nutraceutical markets.
Sky Medical Technology Limited develops innovative neuromuscular electro-stimulation medical devices aimed at enhancing vascular health. Their flagship products include the geko device, which stimulates the common peroneal nerve to activate muscle pumps and improve blood flow, and the firefly device, designed for athletes to enhance lower limb circulation for quicker recovery. The company's OnPulse™ therapy represents a significant advancement in bioelectronic medicine, offering clinically proven solutions for various acute and chronic circulatory conditions, including the prevention of blood clots, treatment of swelling post-surgery, and management of non-healing wounds. These devices are utilized by healthcare professionals, including surgeons, nurses, physiotherapists, and podiatrists, across NHS and private hospitals, as well as in clinical studies. Sky Medical Technology distributes its products globally, reaching markets in Asia, Europe, the Middle East, and North America. Founded in 2006 and based in High Wycombe, United Kingdom, the company addresses the needs of over forty million individuals facing vascular-related health challenges.
Connect Childcare are proud to be helping nurseries with their fully integrated management, observation & communication software systems. Our products are making nurseries more efficient so that their staff can spend more time developing the children in their care.
Arterius Limited is focused on developing an innovative bio-resorbable coronary scaffold, commonly referred to as a stent. This next-generation device is designed to dissolve over a period of 12 to 24 months, becoming absorbed by the body, which eliminates the need for surgical removal. By offering a solution that minimizes the frequency of surgeries or medical interventions, Arterius aims to enhance the postoperative quality of life for patients. The scaffold is engineered to match the delivery ease of traditional bare metal and drug-eluting stents while reducing acute platelet adherence and thrombus formation, providing a safer and more effective alternative in cardiovascular treatments.